NeuropaCalm
  • HOME
  • PATIENTS
  • ANSWERS
  • ABOUT US
  • NEWS
  • CONTACT
  • LOG IN |>>

An Urgent Call to Action: Time to Offer More Effective Peripheral Neuropathy Management Options

4/7/2025

0 Comments

 
Picture
Roughly 20 million individuals in the United States suffer from peripheral neuropathy, a progressive, debilitating condition with long-term implications for independence, longevity and quality of life. Shockingly, this figure likely falls short of the true prevalence, as experts suggest that around 30 million diabetics may be affected, often without awareness or proper diagnosis. 

The complex symptoms associated with peripheral neuropathy can impede accurate identification, leading to frequent misdiagnosis and insufficient treatment. As the number of individuals impacted by this condition continues to grow, it is imperative that we adopt effective management strategies to address this pressing health issue. 

Read More
0 Comments

    ARTICLES

    September 2025
    August 2025
    July 2025
    June 2025
    May 2025
    April 2025
    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    August 2024
    July 2024
    May 2024
    April 2024
    March 2024
    January 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022

    RSS Feed

Picture
Manufactured in FDA registered US facility conforming to GMP & CRF800.
TEL: (775) 382-1415
HOURS: 8:00 am - 4:00 pm PST (Mon-Fri)
EMAIL: [email protected]
ADDRESS: 7750 W 4th St Unit 122  Reno NV 89523

    Subscribe to our newsletter 

    Stay informed about diabetic peripheral neuropathy and the impactful work of medical professionals in this field.
Subscribe to Newsletter
Picture
NeuropaCalm® name and logo are registered trademarks. © 2024 NeuropaCalm
​ALL RIGHT RESERVED
​PRIVACY POLICY
REPAIRS
 Site powered by Good Ink
  • HOME
  • PATIENTS
  • ANSWERS
  • ABOUT US
  • NEWS
  • CONTACT
  • LOG IN |>>